G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and one of the most successful therapeutic targets in modern medicine, with approximately 34% of FDA-approved ...
When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer solutions that are not physically sound. Subscribe to our newsletter for the latest ...
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...
Researchers from David Baker's lab (University of Washington) have designed this antibody from scratch to neutralize a deadly toxin from C. difficile. [Ian Haydon] “Life could not exist without ...
Artificial intelligence (AI)-based drug developer Isomorphic Labs said it has raised $600 million in its first external funding round, with the proceeds expected to accelerate its research and ...
Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Hematopoietic progenitor kinase 1 (HPK1), a member of the Ste20 serine/threonine kinases family, negatively regulates T cell function and is considered a promising target for immunotherapy. Despite ...
This process is costly, time-consuming, and has a low success rate. KAIST researchers have developed an AI model that, using only information about the target protein, can design optimal drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results